2008
DOI: 10.1021/ci800138n
|View full text |Cite
|
Sign up to set email alerts
|

Predicting Kinase Selectivity Profiles Using Free-Wilson QSAR Analysis

Abstract: Kinases are involved in a variety of diseases such as cancer, diabetes, and arthritis. In recent years, many kinase small molecule inhibitors have been developed as potential disease treatments. Despite the recent advances, selectivity remains one of the most challenging aspects in kinase inhibitor design. To interrogate kinase selectivity, a panel of 45 kinase assays has been developed in-house at Pfizer. Here we present an application of in silico quantitative structure activity relationship (QSAR) models to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 47 publications
0
30
0
Order By: Relevance
“…In addition to looking at the kinase structure, the available structure-activity data can be used to look for kinases that are inhibited by structurally similar compounds [102,125]. The distances between key features in the kinases and in possible inhibitors can be compared [138].…”
Section: Predicting Specificity and Selectivitymentioning
confidence: 99%
“…In addition to looking at the kinase structure, the available structure-activity data can be used to look for kinases that are inhibited by structurally similar compounds [102,125]. The distances between key features in the kinases and in possible inhibitors can be compared [138].…”
Section: Predicting Specificity and Selectivitymentioning
confidence: 99%
“…Recently, we have used selectivity data generated here to develop quantitative SAR (QSAR) models to predict the selectivity profiles of 2 series. 32 In summary, we have developed and used a panel of biochemical kinase assays for selectivity screening of compounds. Profiles generated from the panel currently have valuable utility throughout the drug discovery process.…”
Section: Figmentioning
confidence: 99%
“…Such profiling means that scientists are faced with increasing amounts of data that need to be distilled into human sense. It would be powerful to have a good single selectivity value for quantitatively steering the drug discovery process, for measuring progress of series within a program, for computational drug design [10-12], and for establishing when a compound is sufficiently selective. However, in contrast to, for instance, lipophilicity and potency, where values such as logP or binding constant (K d ) are guiding, quantitative measures for selectivity are still under debate.…”
Section: Introductionmentioning
confidence: 99%